Status and phase
Conditions
Treatments
About
The research study is being conducted to test an experimental vaccine to potentially prevent cancer for people with BRCA1 or BRCA2 mutations. This study will test if the vaccine is safe (without significant side effects) and test a new way of administering vaccines. It will also test whether the vaccine activates your immune system.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Cohort A Inclusion Criteria:
Cohort B Inclusion Criteria
Cohort A Exclusion Criteria
Cohort B Exclusion Criteria
Primary purpose
Allocation
Interventional model
Masking
44 participants in 2 patient groups
Loading...
Central trial contact
Alex Torres
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal